7. In Schedule 2 (controlled drugs subject to the requirements of regulations 14, 15, 16, 18, 19, 20, 21, 23, 26 and 27)—
(a)in the heading, after “16,”, insert “16A,”;
(b)in paragraph 1, at the appropriate place insert “Cannabis-based product for medicinal use in humans”; and
(c)after paragraph 5 insert—
“5A. But paragraphs 2 to 5 only apply in respect of a cannabis based product for medicinal use in humans if the cannabis based product that would, as a consequence of paragraphs 2 to 5, be specified in this Schedule but for the operation of this paragraph, is produced for medicinal use in humans.”.